Aclaris Therapeutics
ACRS
#6638
Rank
$0.86 B
Marketcap
$5.91
Share price
-2.96%
Change (1 day)
260.37%
Change (1 year)

Earnings for Aclaris Therapeutics (ACRS)

Earnings in 2026 (TTM): -$69.67 Million USD

According to Aclaris Therapeutics's latest financial reports the company's current earnings are $8.36 Million USD. In 2025 the company made an earning of -$64.93 Million USD, an increase over its 2024 earnings that were of -$0.14 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aclaris Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$69.67 Million7.3%
2025 -$64.93 Million-50.84%
2024 -$0.14 Billion48.64%
2023 -$88.85 Million2.23%
2022 -$86.91 Million-4.35%
2021 -$90.87 Million77%
2020 -$51.34 Million-54.79%
2019 -$0.12 Billion-5.87%
2018 -$0.13 Billion71.46%
2017 -$70.36 Million46.33%
2016 -$48.08 Million133.81%
2015 -$20.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-$0.15 Billion 115.19%๐Ÿ‡บ๐Ÿ‡ธ USA